Olimel 7.6% 7 g (Soybean Oil EMULSION) 7 G

Olime 7.6% 7G is an intravenous emulsion containing soybean oil, designed to provide essential fatty acids and calories for nutritional support. This product is suitable for patients requiring parenteral nutrition.

Strength

7 G

Manufacturer / TM Owner

BAXTER CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Olime 7.6% 7G is primarily used for intravenous nutrition, supplying essential fatty acids and calories to patients who cannot consume food orally. It is often utilized in clinical settings to support overall health and nutritional needs. This emulsion is commonly used for what is soybean oil emulsion used for in medical nutrition therapy.

Side Effects

When administered intravenously, Olime 7.6% 7G provides essential fatty acids that support cellular function and overall health. Patients may experience improved nutritional status and energy levels. However, individual responses can vary, and it is important to monitor for any adverse reactions.

Precautions & Warnings

Olime 7.6% 7G should be handled with care to ensure sterility and proper administration. It is crucial to follow medical guidelines for intravenous nutrition to avoid complications. Patients with known allergies to soybean oil or any of the components should avoid using this product.

Avoid Interactions

Olime 7.6% 7G may interact with other medications or supplements, particularly those affecting lipid metabolism. It is important to consult with a healthcare provider before combining this emulsion with other treatments. Additionally, interactions with alcohol or other intravenous solutions should be carefully monitored.

Frequently Asked Questions

Olime 7.6% 7G is used for intravenous nutrition, providing essential fatty acids and calories to patients who cannot consume food orally.

Olime 7.6% 7G is administered intravenously, typically in a clinical setting under medical supervision.

Common effects include improved nutritional status and energy levels, though individual responses can vary.

Yes, it is important to ensure sterility and proper administration. Patients with allergies to soybean oil should avoid this product.

Yes, it may interact with medications affecting lipid metabolism. Consult a healthcare provider before combining with other treatments.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.